Press release
Bioresorbable Polymers Market is set foe steady growth to USD 3.3 billion by 2031, Strong CAGR of 13.4% | Key Players:- Ashland Global Holdings Inc, Corbion N.V, Evonik Industries AG
DataM Intelligence unveils its latest report on the "Bioresorbable Polymers Market size 2026," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.
Download a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/bioresorbable-polymers-market?pratik
United States: Key Industry Developments
✅ December 2025: Evonik expanded its RESOMER bioresorbable polymer production facility in Alabama, enhancing capacity for PLA-based medical implants and drug delivery systems to meet surging demand from orthopedic applications. This move supports faster degradation profiles and biocompatibility improvements amid rising minimally invasive surgeries.
✅ October 2025: Mallinckrodt Pharmaceuticals launched a new line of PLGA copolymers tailored for controlled-release drug-eluting stents, gaining FDA fast-track status for cardiovascular use. The innovation reduces long-term inflammation risks and aligns with U.S. trends in personalized medicine.
✅ August 2025: Corbion announced a strategic partnership with a leading U.S. medical device firm to develop P(L)LA polymers for tissue engineering scaffolds, boosting regenerative medicine adoption. This addresses scalability challenges while targeting orthopedic and dental markets with enhanced mechanical strength.
Asia Pacific / Japan: Key Industry Developments
✅ November 2025: Mitsubishi Chemical launched its bioresorbable L-lactide polymer variant for orthopedic screws in Japan, featuring optimized resorption rates for bone regeneration in aging populations. The product integrates with PMDA-approved protocols to reduce revision surgeries.
✅ September 2025: Toray Industries collaborated with Japanese hospitals on PCL-based vascular scaffolds using bioresorbable polymers, advancing clinical trials for peripheral artery disease treatments. This supports Japan's focus on sustainable biomaterials amid healthcare investments.
✅ July 2025: Unitika Ltd introduced a new polycaprolactone (PCL) grade for wound healing meshes, emphasizing breathability and full resorption within 6-12 months. The launch caters to rising dermatological and surgical needs in Asia Pacific's medical tourism sector.
M&A Activity
Evonik Industries strengthened biomaterials portfolio through acquisitions in specialty polymers, enhancing cardiovascular and orthopedic offerings. No other major 2025 mergers reported, though strategic consolidations continue amid rising demand.
FDA Approvals
September 2025 approvals granted for advanced bioresorbable polymer-based implants, focusing on biocompatibility for minimally invasive procedures and tissue engineering. These clearances accelerate adoption in orthopedics and cardiology applications.
Partnerships
Poly-Med Inc. partnered with a leading medical device firm to co-develop next-gen bioresorbable vascular scaffolds, combining material expertise with clinical insights. PCAS collaborated with orthopedic developers on resorbable fixation devices.
Product Developments
DSM Biomedical launched three innovative polymer formulations for cardiovascular uses in the past year. Lubrizol introduced Carbopol Fusion S-20, a biodegradable polymer for medical applications with low carbon footprint
Competitive Landscape
Ashland Global Holdings Inc, Corbion N.V, Evonik Industries AG, Poly-Med Inc, KLS Martin Group, Foster Corporation, Zeus Industrial Products, Seqens Group, REVA Medical, LLC, Nomisma Healthcare Pvt. Ltd.
Growth Drivers:-
Surging minimally invasive surgeries and implants reduce recovery time, boosting need for degradable stents, sutures, and scaffolds.
Chronic diseases like cardiovascular issues and orthopedics drive orthopedic fixation and drug delivery applications.
Advancements in PLA/PLGA polymers improve biocompatibility, controlled degradation, and mechanical strength for broader adoption.
Rising healthcare spending in North America (33%+ share) and fast-growing Asia-Pacific via R&D investments.
Regulatory approvals for bioresorbable devices and shift from permanent implants minimize long-term risks.
Sustainability focus favors eco-friendly, biodegradable alternatives over traditional plastics in medtech
📌 Buy Now & Unlock 360° Market Intelligence:https://www.datamintelligence.com/buy-now-page?report=bioresorbable-polymers-market?pratik
Regional Highlights
North America leads the bioresorbable polymers market with the largest share, driven by advanced healthcare infrastructure, high R&D investments, and demand for minimally invasive surgeries, particularly in the US. Asia Pacific exhibits the fastest growth, fueled by rapid healthcare modernization, aging populations, rising investments in countries like China and India, and expanding production of materials like Polylactic Acid (PLA).
Europe Insights
Europe shows steady expansion due to supportive reimbursement policies, increasing orthopedic and drug delivery applications, and regulatory harmonization across countries like Germany and the UK. Growth is supported by high healthcare spending and a focus on sustainable medical devices.
Emerging Regions
Middle East & Africa remains nascent but is growing moderately, with stronger potential in the Middle East (UAE, Saudi Arabia) from medical tourism and infrastructure upgrades. Latin America trails due to economic variability but benefits from rising access to advanced implants.
Get Customization in the report as per your requirements:https://www.datamintelligence.com/customize/bioresorbable-polymers-market?pratik
Market Segmentation:-
Polylactic Acid (PLA)
Polylactic acid (PLA) dominates as the largest segment, valued for high biocompatibility, tunable degradation rates, and ease of processing into implants. It excels in orthopedic fixation devices and scaffolds. PLA holds 34.6% market share as of 2022, with some reports citing 33.5% in 2024.
Polyglycolic Acid (PGA)
Polyglycolic acid (PGA) offers rapid degradation and high tensile strength, ideal for absorbable sutures and short-term implants. It supports bone regeneration in orthopedics. PGA commands 22% market share based on 2024 data.
Poly(lactic-co-glycolic acid) (PLGA)
PLGA, a copolymer of PLA and PGA, provides controlled degradation for precise drug release profiles and tissue engineering. It leads in drug delivery systems due to customizable ratios like 50:50. PLGA captured the top share at 28% in 2021 assessments.
Polycaprolactone (PCL)
Polycaprolactone (PCL) features slow degradation and flexibility, suiting long-term drug delivery and 3D-printed scaffolds. It enhances soft tissue repair. PCL accounts for 14.2% market share per latest breakdowns.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioresorbable Polymers Market is set foe steady growth to USD 3.3 billion by 2031, Strong CAGR of 13.4% | Key Players:- Ashland Global Holdings Inc, Corbion N.V, Evonik Industries AG here
News-ID: 4342341 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Personalized Medicine Market to Reach US$ 976.30 Billion by 2031 at 7.8% CAGR; N …
The Global Personalized Medicine Market reached US$ 538.25 billion in 2023 and is expected to reach US$ 976.30 billion by 2031, growing at a CAGR of 7.8% during the forecast period 2024-2031. Market growth is driven by advancements in genomics, increasing adoption of targeted therapies, and rising demand for tailored treatment approaches that improve clinical outcomes.
Personalized medicine involves customizing medical treatment based on an individual's genetic profile, lifestyle, and disease…
United States Logistics Market is seeing a strong growth at a CAGR of 7.3%, Key …
The Logistics market size was valued at USD 3,784.4 billion in 2023 and is projected to reach USD 5,961.0 billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030. The market represents a dynamic and rapidly evolving sector that plays a crucial role in global trade and commerce.
DataM Intelligence unveils its latest report on the "Logistics market size 2026," offering an in-depth analysis of market trends, growth…
Cell Therapy Market to Reach US$ 48.98 Billion by 2033 at 21.4% CAGR; North Amer …
The Global Cell Therapy Market reached US$ 6.52 billion in 2024 and is expected to reach US$ 48.98 billion by 2033, growing at a CAGR of 21.4% during the forecast period 2025-2033. Market growth is driven by increasing research and development activities, rising regulatory approvals, and growing demand for advanced therapeutic alternatives to conventional treatments for life-threatening and chronic diseases.
Cell therapy involves the administration of living cells to restore, replace,…
Milking Robots Market Set for Explosive Growth to USD 5,923.29 Million by 2030, …
The Global Milking Robots Market reached USD 2,289.28 million in 2024 and is projected to reach USD 5,923.29 million by 2030, growing at a CAGR of 16.7% during the forecast period 2024-2031.
Market growth is driven by escalating labor shortages in dairy farming, rising demand for automation to boost operational efficiency, and increasing adoption of precision dairy technologies amid expanding global milk production needs. Advancements in robotics and AI integration, supportive…
More Releases for Poly
Poly(vinyl Acetate) Market Size Report 2025
On Mar 8, 2025, Global Info Research released a research report titled "Global Poly(vinyl Acetate) Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031". This report provides detailed data analysis of the Poly(vinyl Acetate) market from 2020 to 2031. Including the market size and development trends of Poly(vinyl Acetate) Market, it analyzes market size indicators such as sales, sales volume, average price and CAGR, it also provides a…
Poly Aluminium Chloride Market Research Report 2023
Polyaluminium Chloride Market
Polyaluminium chloride (PAC) is manufactured in both liquid and powder form. The product is used in deodorants and antiperspirants, as a flocculant in water purification, in treatment of drinking / potable water, wastewater treatment and paper sizing.
In this report, poly alumnium chloride is classified into liquid and powder type. All the poly alumnium chloride products are converted into 30% Al2O3 content.
Due to the COVID-19 pandemic, the global…
Poly-Vents Market to Witness Remarkable Growth | Filtration Group Corporation; P …
Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “Poly-Vents Market Analysis and Forecast, 2020 – 2027”. In this report, Researchers have analysed Strength, Weakness, opportunities and threats in the market and provides the unbiased picture of the market with the informative knowledge. The Poly-Vents Market report additionally states import/trade utilization, free market activity figures, cost, value, volume and gross edges.
The study bridges the historical…
Poly-Vents Market To Witness Astonishing Growth | Competitive Outlook By Filtrat …
The Latest survey report on Poly-Vents Market?research gives a holistic overview of the growth and other aspects of the industry in vital countries (regions). The regions provided in this market document show the geographical boundaries across the globe. This report is a wonderful guide to achieve an information or key data about market, emerging trends, product usage, customer inclinations, motivating factors for customers, competitor strategies, brand positioning, future trends, customer…
Poly Adenosine Diphosphate Ribose Polymerase Market Drivers
Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in restoring the damage in DNA caused due to various factors such as exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors aid in blocking the enzyme important for the repair…
Poly Adenosine Diphosphate Ribose Polymerase Market Drivers
Poly adenosine diphosphate ribose polymerase (PARP) is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain and transfer them to the target proteins. These proteins aid in restoring the damage in DNA caused due to various factors such as exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors aid in blocking the enzyme important for the repair…
